2025-03-01 2026-02-28 false No description of principal activity Acting Office - Tax and Accounts 1.0 13920980 bus:FullAccounts 2025-03-01 2026-02-28 13920980 bus:Micro-entities 2025-03-01 2026-02-28 13920980 bus:AuditExempt-NoAccountantsReport 2025-03-01 2026-02-28 13920980 bus:SmallCompaniesRegimeForAccounts 2025-03-01 2026-02-28 13920980 bus:PrivateLimitedCompanyLtd 2025-03-01 2026-02-28 13920980 2025-03-01 2026-02-28 13920980 2026-02-28 13920980 bus:RegisteredOffice 2025-03-01 2026-02-28 13920980 core:WithinOneYear 2026-02-28 13920980 core:AfterOneYear 2026-02-28 13920980 2024-02-29 13920980 bus:Director1 2025-03-01 2026-02-28 13920980 bus:Director1 2026-02-28 13920980 bus:Director1 2024-02-29 2025-02-28 13920980 bus:CompanySecretary1 2025-03-01 2026-02-28 13920980 bus:LeadAgentIfApplicable 2025-03-01 2026-02-28 13920980 2024-02-29 2025-02-28 13920980 2025-02-28 13920980 core:WithinOneYear 2025-02-28 13920980 core:AfterOneYear 2025-02-28 13920980 bus:EntityAccountantsOrAuditors 2024-02-29 2025-02-28 13920980 core:CostValuation core:Non-currentFinancialInstruments 2026-02-28 13920980 core:CostValuation core:Non-currentFinancialInstruments 2025-02-28 13920980 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2026-02-28 13920980 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2026-02-28 13920980 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-02-28 13920980 core:ShareProfitOrLossIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-02-28 13920980 core:ProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2026-02-28 13920980 core:ImpairmentReversalProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2026-02-28 13920980 core:ForeignExchangeDifferencesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-02-28 13920980 core:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-02-28 13920980 core:TransfersBetweenInvestmentClassesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-02-28 13920980 core:Non-currentFinancialInstruments 2026-02-28 13920980 core:Non-currentFinancialInstruments 2025-02-28 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 13920980
England and Wales

 

 

 


Unaudited Financial Statements

for the year ended 28 February 2026

for

THE SCENTED VAULT LTD

 
 
2026
£
    2025
£
 
Current assets 23  295 
Creditors: amount falling due within one year (1,616) (1,316)
Net current assets/(liabilities) (1,593) (1,021)
Total assets less current liabilities (1,593) (1,021)
Net assets/(liabilities) (1,593) (1,021)
 
Capital and reserves (1,593) (1,021)
 



Notes to the Accounts
Statutory Information
The Scented Vault Ltd is a private limited company, limited by shares, domiciled in England and Wales, registration number 13920980, registration address 4 Inglewood Close, High Harrington, Workington, CA14 4LE, United Kingdom.

The presentation currency is £ sterling.
1.

Accounting Policies

Basis of accounting
The financial statements are prepared under the historical cost convention and in accordance with the FRS 105 Financial Reporting Standard for Micro Entities (effective January 2016).
2.

Average number of employees

Average number of employees during the year was 0 (2025: 0).

Director's Responsibilities:
  1. For the year ended 28 February 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
  2. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Signed on behalf of the board of directors:


---------------------------------------------
Daniel Carey
Director

Date approved: 23 October 2026
1